Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cell Source, Inc. (CLCS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 08/23/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 08/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/16/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 12/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 12/02/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 11/02/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 07/21/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 05/06/2022 |
8-K
| Quarterly results |
| 04/21/2022 |
3
| Verstraete George (Director) has filed a Form 3 on Cell Source, Inc. |
| 04/15/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 03/31/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/11/2022 |
8-K
| Quarterly results |
| 11/15/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/12/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/11/2021 |
4
| Soave Darlene (10% Owner) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 800,000 options to buy
@ $1.25, valued at
$1M
|
|
| 07/07/2021 |
4
| ZOLTY DAVID (Director) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 4,860 shares
@ $0.75, valued at
$3.6k
|
|
| 07/07/2021 |
4
| Soave Darlene (10% Owner) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 59,507 shares
@ $0.75, valued at
$44.6k
|
|
| 07/07/2021 |
4
| Brown Dennis M (Director) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 2,976 shares
@ $0.75, valued at
$2.2k
|
|
| 07/07/2021 |
4
| FRIEDMAN BENZION ABRAHAM (10% Owner) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 19,440 shares
@ $0.75, valued at
$14.6k
|
|
| 06/10/2021 |
4
| ZOLTY DAVID (Director) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 1,350 shares
@ $0.75, valued at
$1k
Acquired 1,668 shares
@ $0.75, valued at
$1.3k
Acquired 1,361 shares
@ $0.75, valued at
$1k
Acquired 1,339 shares
@ $0.75, valued at
$1k
Acquired 6,420 shares
@ $0.75, valued at
$4.8k
Acquired 4,887 shares
@ $0.75, valued at
$3.7k
Acquired 4,941 shares
@ $0.75, valued at
$3.7k
Granted 3,000 convertible preferred
@ $0.75, valued at
$2.3k
Granted 7,888 convertible preferred
@ $0.75, valued at
$5.9k
Granted 300,000 options to buy
@ $0.75, valued at
$225k
Disposed/sold 300,000 options to buy
@ $0.75, valued at
$225k
|
|
| 06/10/2021 |
4
| FRIEDMAN BENZION ABRAHAM (10% Owner) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Acquired 5,400 shares
@ $0.75, valued at
$4.1k
Acquired 6,672 shares
@ $0.75, valued at
$5k
Acquired 5,444 shares
@ $0.75, valued at
$4.1k
Acquired 5,356 shares
@ $0.75, valued at
$4k
Acquired 25,675 shares
@ $0.75, valued at
$19.3k
Acquired 19,547 shares
@ $0.75, valued at
$14.7k
Acquired 19,672 shares
@ $0.75, valued at
$14.8k
Granted 12,000 convertible preferred
@ $0.75, valued at
$9k
Granted 31,553 convertible preferred
@ $0.75, valued at
$23.7k
Granted 300,000 options to buy
@ $0.75, valued at
$225k
Disposed/sold 300,000 options to buy
@ $0.75, valued at
$225k
|
|
| 06/10/2021 |
SC 13D
| SHIMRAT ITAMAR reports a 5.7% stake in CELL SOURCE, INC. |
| 06/10/2021 |
4
| SHIMRAT ITAMAR (President, Treasurer and CFO) has filed a Form 4 on Cell Source, Inc.|
Txns:
| Granted 750,000 options to buy
@ $1, valued at
$750k
Granted 600,000 options to buy
@ $1, valued at
$600k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/20/2021 |
SC 13D
| Soave Darlene reports a 9.9% stake in CELL SOURCE, INC. |
| 04/20/2021 |
3
| Soave Darlene (Director) has filed a Form 3 on Cell Source, Inc. |
| 04/15/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 04/01/2021 |
8-K
| Quarterly results |
| 03/31/2021 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 12/29/2020 |
SC 13G
| REISNER YAIR reports a 10.6% stake in CELL SOURCE, INC. |
|
|
|